← Back
$UTHR All transactions

UNITED THERAPEUTICS Corp

▼ SELL 10b5-1 Plan

$ Value

$120K

Shares

240

Price

$499

Filed

Dec 16

Insider

Name

EDGEMOND JAMES

Title

CFO AND TREASURER

CIK

0001636178

Roles

Officer

Transaction Details

Transaction Date

2025-12-15

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

8,383

Footnotes

This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on August 5, 2025. | The amount of common stock beneficially owned by the Reporting Person in the Reporting Person's Form 4s filed November 5, 12 and 18, 2025 did not include 24 shares acquired by the Reporting Person on September 4, 2025 under the United Therapeutics Corporation Stock Purchase Plan, which error caused the reporting person's common stock ownership to be underreported by 24 shares on such Form 4s. The amount of common stock beneficially owned by the Reporting Person in this Form 4 includes such shares. | This transaction was executed in multiple trades at prices ranging from $491.19 to $491.92. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. | This transaction was executed in multiple trades at prices ranging from $492.28 to $493.24. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. | This transaction was executed in multiple trades at prices ranging from $493.35 to $494.34. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. | This transaction was executed in multiple trades at prices ranging from $494.52 to $495.38. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. | This transaction was executed in multiple trades at prices ranging from $495.52 to $496.34. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. | This transaction was executed in multiple trades at prices ranging from $496.59 to $497.39. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. | This transaction was executed in multiple trades at prices ranging from $497.60 to $498.45. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. | This transaction was executed in multiple trades at prices ranging from $498.88 to $499.80. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. | This transaction was executed in multiple trades at prices ranging from $499.92 to $500.40. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Filing Info

Accession No.

0001636178-25-000010

Form Type

4

Issuer CIK

0001082554

EDGEMOND JAMES's History

Date Ticker Type Value
2026-04-20 UTHR M $1.4M
2026-04-20 UTHR $504K
2026-04-20 UTHR $885K
2026-04-20 UTHR $254K
2026-04-20 UTHR $581K
2026-04-20 UTHR $806K
2026-04-20 UTHR $397K
2026-04-20 UTHR $289K
2026-04-20 UTHR $197K
2026-04-20 UTHR $284K

Other Insiders at UTHR (90d)

Insider Bought Sold Last
ROTHBLATT MARTINE A
Chairperson & CEO
$193.8M 2026-04-22
KURZWEIL RAY $2.4M 2026-03-04
PATUSKY CHRISTOPHER $579K 2026-04-17
MAHON PAUL A
EVP & GENERAL COUNSEL
$25.9M 2026-04-16
CAUSEY CHRISTOPHER $1.3M 2026-03-30
Thompson Tommy G $2.1M 2026-03-26
Olian Judy D. $417K 2026-03-23
EDGEMOND JAMES
CFO AND TREASURER
$50.8M 2026-04-20
BENKOWITZ MICHAEL
PRESIDENT AND COO
$60.0M 2026-03-15
MALCOLM JAN $97K 2026-03-17